ADVB News

Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, announced terms for its IPO on Wednesday. The Tainan, Taiwan-based company plans to raise $113 million by offering 25 million shares at a price range of $4 to $5. At the midpoint of the proposed range, Advanced Biomed would command a market value of $563 million. Operating through...read more

There were no IPOs this past week, as the sole scheduled offering (AZTR) delayed to the week ahead. Along with no post-Memorial Day launches, the pipeline was quiet with no new initial filings. The summer IPO market is off to a slow start coming out of May, which was the year’s slowest month for IPOs to date but also ...read more

Four sizable IPOs raised a combined $4.9 billion in May, the biggest month for proceeds since December 2021. May activity was well below the 10-year average for deal count (19 IPOs) but on par for proceeds ($5.0B), and the month now accounts for two-thirds of 2023 IPO proceeds to date thanks to its slate of large deals. Issuance was led by J&J’s Kenvue...read more

Two IPOs priced this past week, each raising more than $200 million, while one small issuer delayed (AZTR). They were joined by one SPAC. Six IPOs and one SPAC submitted initial filings. Leading the week, Cummins spin-off Atmus Filtration (ATMU) priced at the midpoint to raise $275 million at a $1.6 billion market cap. Primarily operating under the Fleetguard...read more